For people living with Parkinson’s disease, the current drug used to treat it is effective, but also short-lived. Symptoms like tremors or changes in gait return and can affect a person’s quality of ...
With the potential to be a first-in-class drug, seltorexant is a ... unmet need for new therapies to treat patients experiencing depression and insomnia, and most importantly, to improve outcomes ...
“Its treatment effects are similar to antidepressant medications among adults ... Sixty-two women assessed for insomnia and depressive symptoms participated in the study—with half randomly ...
Iambic, which has previously won investment from tech giant Nvidia (NVDA.O), opens new tab, published details of its new AI drug discovery model, named "Enchant". Enchant was trained on large ...